Status:
RECRUITING
Economic Navigation and Strengthening to Research Unrestricted Services for Transgender Women (ENTRUST)
Lead Sponsor:
University of Central Florida
Collaborating Sponsors:
Sunserve
Survivor's Pathway
Conditions:
Transgender Women
Aids
Eligibility:
MALE
18+ years
Phase:
NA
Brief Summary
The overall hypothesis is that stabilizing transgender women financially while providing them tailored counselling will increase their odds of them linking to substance use services, PrEP services if ...
Detailed Description
There continues to be a gap in the extant literature on the relationship between substance abuse and achievement of viral suppression (VS) through adherent antiretroviral treatment (ART) or PrEP uptak...
Eligibility Criteria
Inclusion
- Aged ≥18 years
- Male at birth
- Identify as a woman/transgender woman
- Should not be consistently using PrEP (less than four doses per week)
- Should not have any known allergy or adverse reaction to PrEP or the active drug tenofovir in ART. One of the goals of the study is to move more people into a PrEP program
- Be able to speak and understand spoken English and/or Spanish (including persons who cannot read or write)
- Have a smart phone that can take pictures
Exclusion
- Unwilling to adhere to study procedures
- Participation in an HIV vaccine trial
- Have a life-threatening SUD\*
- Any condition, that in the opinion of the study staff, would make participation in the study unsafe, or interfere with achieving the study objective such as medical conditions which prevents the use of PrEP
- Unable to provide consent
Key Trial Info
Start Date :
July 11 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2027
Estimated Enrollment :
110 Patients enrolled
Trial Details
Trial ID
NCT06202898
Start Date
July 11 2023
End Date
June 1 2027
Last Update
December 6 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Central Florida
Orlando, Florida, United States, 32827